Worldwide Endocrinology Calendar

(5 Dec 2019) Weigh the latest perspectives, with Dr. Stephen Harrison, on wet biomarkers, imaging, and combination tests, focusing on their uses for: Screening and diagnosis of NASH with moderate/severe fibrosis; Assessing therapeutic response to NASH treatment; Assessing long-term patient outcomes. 12:00 PM Eastern Time (9:00 AM PT; 6:00 CET)

(11 Dec 2019) Weigh the benefits and risks of available approaches to managing NASH, including lifestyle and vitamin E; and understand the place of compounds that target insulin resistance with Juan Pablo Frias, MD (12:00 PM Eastern Time (9:00 AM PT; 6:00 CET)

(18 Dec 2019) ThyroAlex 10 is the regular semiannual thyroid themed conference organized by Alexandria Thyroid Association and Endocrinology unit, Alexandria faculty of Medicine. As established, the conference will be held on 2 days, the first will include small groups interactive workshops by thyroid experts. The second day is a full day conference with lectures and lecturers from Egyptian national Universities handling Thyroid day-to-day practice

(3 Mar 2020) The aim of the organizing committee is to propagate the knowledge about care and cure of patients with pituitary or skull base pathology. The symposium focuses on various aspects of pituitary and skull base disease. A national and international faculty will be present to elucidate on radiology, radiotherapy, endocrinology, surgery (also orbit), next to research topics.

(4 Mar 2020) AsAES 2020: Controversies in Endocrine Surgery, will focus on key areas of Endocrine Surgery including: benign and malignant thyroid disease, parathyroid disease, and management of adrenal pathology. We are pleased to partner with the Endocrine Society of Australia - ESA, for a combined multidisciplinary program on Day 2 - Friday 06 March, which will focus on areas of combined interest to both Endocrine Surgeons and Endocrinologists.

(13-14 Mar 2020) The symposium is a two-day program. The first day, aims to provide a foundation for practicing physicians in understanding the evolving role of clinical molecular testing and its integration with the contemporary ultrasound imaging for diagnosis and management of thyroid nodules and cancer. The plenary session on the second day of the symposium, will review the clinical guidelines, address the ontroversies and bring new insight to the molecular and genomic theranostics in a didactic and interactive format. There will also be a Scientific Paper Presentations/Case Discussions session and a Multidisciplinary Tumor Board session, led by experts in the field to offer a platform for physicians in training and all academic and practicing physicians to present and discuss their research work and clinical experience.

(15 Mar 2020) This symposium aims to provide a high visibility platform to scientists who use modern molecular genetic tools to discover inter-organ communications, and therefore to illustrate how much our molecular and genetic understanding of whole-organism physiology has progressed in the last 20 years.

(21 Mar 2020) Harvard Medical School has selected over 40 faculty and outside experts to present the most up to date, evidence-based approach to endocrine problems. This course will cover many topics such as: osteoporosis, Type 1 and Type 2 diabetes, hypercholesterolemia, pituitary tumors, menopause, thyroid abnormalities, reproductive dysfunction, and a broad spectrum of other clinical problems in endocrinology.

(24-26 Mar 2020) Endocrine Fellows Series: Type 1 Diabetes Care and Management is a comprehensive conference for adult and pediatric endocrine fellows interested in type 1 diabetes (T1D). The unique and highly-sought after program is an opportunity learn from leaders in the field through interactive sessions, small group discussions, and hands-on learning. The curriculum provides comprehensive education not typically taught in fellowship and opportunities to connect with thought-leaders and peers.

(26-27 Mar 2020) The symposium will bring together basic, translational, and clinical scientists from different disciplines who study the biochemistry, molecular biology, cell biology, physiology, and pathophysiology of the CaSR and clinical disorders of CaSR function. The program will feature recent research on the role of the CaSR in skeletal development and physiology, vascular and pulmonary functions, neuronal injury, parathyroid physiology, mineral and energy metabolism, exocrine and transport functions in the gut and kidney, diabetes, inflammation, and cancer cell signalling. Clinical uses of CaSR modulators to treat human disorders, novel molecular structures and actions of the CaSR, and interactions of the CaSR with other signalling pathways will also be highlights. ONLY 250 SEATS ARE AVAILABLE. DEADLINE FOR REGISTRATION IS MARCH 24, 2020